Medical AI

An AMWC 2026 award for RRS® HA Long Lasting signals a market shift. How Skin Tech Pharma Group is creating a new category beyond fillers and boosters.

CONMED appoints John Gallagher, a seasoned MedTech CFO, to navigate market headwinds and drive a new chapter of financial performance and shareholder value.

With a $110M boost, Nyxoah is bringing its innovative, battery-free sleep apnea device to the US. Is this the disruption patients have been waiting for?

A partnership between Chef Carla Hall and The Fresh Market shows how retail fundraising directly enables cutting-edge diagnostics and treatments in the fight against Alzheimer's.

A Florida hospital just rebuilt a baby's heart in stages. It's not just a medical first; it's a new blueprint for innovation where execution trumps hype.

With $4.3M in seed funding and a roster of industry titans, Acurion is poised to commercialize its OncoGaze™ AI, aiming to make precision oncology faster.

With a novel FDA clearance for its at-home UVB device, Solius Labs isn't just launching a product; it's creating a new market for personalized medicine.

As patients turn to AI for health advice, a new peer-reviewed framework from Included Health offers a clinically-governed model for safety and trust.

Chronic fatigue, anxiety, and burnout are surging. A new wave of data-driven, integrative medicine claims to have the answer, moving beyond symptoms to the root cause.

Forget perfect guidance. The future of stroke rehab may lie in making mistakes. Israel's Bioxtreme launches Dextreme 2.0, using AI to amplify errors and accelerate recovery.

A new partnership between Medventions and Mitacs aims to fix Canada's innovation gap by embedding engineers directly into clinics. Here's how it works.

Belmont Medical's acquisition of Arcos fuses life-saving devices with smart software, promising a new era of data-driven care for trauma and burn patients.

With a key regulatory win in the UAE, WAT Medical is set to introduce its drug-free neuromodulation devices to a booming Middle Eastern healthcare market.

A new survey reveals Tennessee seniors delay hearing care for years due to cost fears, risking cognitive decline and falls. But are the solutions already here?

Verastem Oncology's combo therapy posts impressive early data in a notoriously deadly cancer, revealing a shrewd strategy for tackling drug resistance.

New research reveals that custom 3D braces can actively correct spinal curves, not just prevent them from worsening. This paradigm shift in non-surgical care offers new hope.

New data on ersodetug reveals a calculated strategy to conquer hyperinsulinism, balancing patient hope with the harsh realities of the biotech market.

A new survey reveals the deep toll of canine skin allergies on pets and owners, exposing a massive unmet need that has pharmaceutical giants racing for a cure.

A new collaboration aims to weaponize the immune system against tough GI cancers. We break down the science, strategy, and nearly $800M per program deal.

FiberSense AG’s new 28-day CGM sensor just won European approval, challenging market leaders. But the real growth signal is its plan to move beyond glucose.